Silver Book Fact

Prevalence of AS in Americans 75+

An estimated 12.4%, or ~2.5 million people ages 75+ in North America, have AS.

Osnabrugge R, Mylotte D, Head S, Van Meighem N, et al. Aortic Stenosis in the Elderly: Disease prevalence and number of candidates for transcathet aortic valve replacement, a meta-analysis and modeling study. Journal of the American College of Cardiology. September 10 2013. http://www.sciencedirect.com/science/article/pii/S0735109713020792. Accessed October 13, 2017

Reference

Title
Aortic Stenosis in the Elderly: Disease prevalence and number of candidates for transcathet aortic valve replacement, a meta-analysis and modeling study.
Publication
Journal of the American College of Cardiology
Publication Date
September 10 2013
Authors
Osnabrugge R, Mylotte D, Head S, Van Meighem N, et al.
Volume & Issue
Volume 62, Issue 11
URL
Read Full Resource

Categories

  • Cost of Disease
  • Age - A Major Risk Factor

Connected Facts

Related Facts

  • Mean 5-Year Cumulative Total Medical Costs Per Medically Managed (No AVR) Severe AS Patient
     
  • SAS patient hospitalization costs
    Symptomatic aortic stenosis (SAS) patients who do not undergo treatment cost Medicare as much as $1.3 billion each year due to rehospitalization, prolonged stays, admissions to skilled nursing facilities, and…  
  • 1 and 6-month mortality rates without treatment for sSAS
    Waiting for treatment for severe symptomatic aortic stenosis (sSAS) can be deadly, with 1-month mortality at 3.7% and 6-month mortality at 11.6% (measured from the time intervention was recommended).  
  • Lifespan of Medicare patients with sSAS who do not undergo treatment
    Medicare patients with severe symptomatic aortic stenosis (sSAS) who do not undergo treatment have an average lifespan of 1.8 years.  
  • Prevalence of AS in Americans 75+
    An estimated 12.4%, or ~2.5 million people ages 75+ in North America, have AS.